Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing
Reexamination Certificate
2006-04-25
2006-04-25
Jones, Dameron L. (Department: 1618)
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
C424S009200
Reexamination Certificate
active
07033573
ABSTRACT:
This invention proposes the existence of an alternate glucose pathway different from that presently accepted and offers different methods of proving this. The proposed alternate glucose pathway considers the cerebral spinal fluid as a major component of the pathway. Based on this, a diagnostic tool for detecting mental disorders and neurological disorders which can not be detected by CT Scan and MRI is proposed. Medications directed at the CSF are also proposed.
REFERENCES:
patent: 6369046 (2002-04-01), Schatzberg et al.
patent: 6620802 (2003-09-01), Schatzberg et al.
Swaab et al, Jornal of Neuroendocrinology, 1994, vol. 6, pp. 681-687.
Peskind et al, Neurology, 2001, vol. 56, pp. 1094-1098.
Joseph K. Belanoff et al., “slowing the Progression of Cognitive Decline in Alzheimer's Disease Using Mifepristone”,Journal of Molecular Neuroscience,vol. 19, 2002, pp. 201-206.
Linda E. Carlson et al., “Relationships between Dehydroepiandrosterone Sulfate (DHEAS) and Cortisol (CRT) Plasma Levels and Everyday Memory in Alzheimer's Disease Patients Compared to Healthy Controls”,Hormones and Behavior 35,1999, pp. 254-263.
Michael T. Falduto et al., “Role of Apolipoprotein E in Neurobiology and the Pathogenesis of Alzheimer's Disease”,Pharmacological Treatment of Alzheimer's Disease,1997 Chapter 12, pp. 287-307.
Suzanne Craft, PhD et al., “Enhancement of Memory in Alzheimer Disease With Insulin and Somatostatin, but Not Glucose”,Arch Gen Psychiatryvol. 56 Dec. 1999, pp. 1135-1140.
Segal MB., “Transport of Nutrients Across the Choroid Plexus”,Microsc Res Tech,2001, 52(1): 38-48, National Library of Medicine (PubMed, Abstract only).
Sommer JB et al., “Does lumbar cerebrospinal fluid reflect ventricular cerebrospinal fluid? A prospective study in patients with external ventricular drainage”,Eur Neurol,2002, 47(4): 224-32, National Library of Medicine (PubMed, Abstract only) (Oct. 2002).
“Insulin, Neurogentics and Memory in Alzheimer's Disease”,Clinical Trials.gov.,Department of Veterans Affairs Medical Research Service Oct. 1999.
“The Evaluation and Follow-up of Patients with Memory Disorder and Normal Volunteers”,Clinical Trials.gov.,National Institute of Mental Health Mar. 21, 1995.
Craft et al., “Insulin Metabolism in Alzheimer's . . . ”,Neuroendocrinology,1999; 70, pp. 146-152.
Craft et al., “Steroid-induced Elevation of Glucose . . . ”,Psyconeuroendocrinology28, 2003, pp. 113-120.
Craft et al., “Enhancement of Memory in . . . ”,Arch Gen Psychiatry,vol. 56, Dec. 1999, pp. 1135-1140.
Craft et al., “Memory Improvement Following . . . ”,Neurobiology of Aging,vol. 17, 1996, pp. 123-130.
Craft et al., “The Role of Insulin Resistance . . . ”,CNS Drugs,2003, 17, pp. 27-45.
Craft et al., “Insulin Effects on . . . ”,Annals of the New York Academy of Sciences903, 2000, pp. 222-228.
Luijpen et al., “Effects of Transcutaneous . . . ”,Neurorehabilitation and Neural . . .18(3), 2004, pp. 166-175.
Verhaagen et al., “Neurotrophin Receptors in . . . ”,Progress in Brain Research,vol. 117, pp. 25 and 72.
Seiger et al., “Intracranial Infusion of Purified . . . ”,Behavioural Brain Research,57, 1993, pp. 255-261.
Fanelli et al., “Long-term Recovery from Unawareness . . . ”,Diabetologia37, 1994, pp. 1265-1276.
Pagano et al., “An in Vivo and in Vitro Study of . . . ”,J. Clin. Invest.,vol. 72, 1983, pp. 1814-1820.
Park et al., “Intracerebroventricular . . . ”,Physiology&Behavior,vol. 68, Issue 4, Feb. 2000 (Abstract).
Olson et al., “Nerve Growth Factor . . . ”,Journal of Neural Transmission4, 1992, pp. 79-95 (Summary).
Elrod et al., “Effects of Alzheimer's Disease . . . ”,Am. J. Psychiatry154:1, Jan. 1997 (Abstract page).
Wolkowitz et al., “DHEA Treatment of . . . ”Neurology2003; 60, pp. 1071-1076 (Abstract page).
Wu et al., “Molecular Changes . . . ”,Journal of Clinical . . .88 (12) pp. 5896-5906 (Abstract page).
Jones Dameron L.
Westerman Hattori Daniels & Adrian LLP
LandOfFree
Diagnoses and treatment of disorders using an alternative... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnoses and treatment of disorders using an alternative..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnoses and treatment of disorders using an alternative... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3568393